Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 1.83
(4.87%)
AUD 1.83
(4.87%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 11.5 Million AUD | 17.41% |
| 2023 | 9.8 Million AUD | 51.74% |
| 2022 | 6.45 Million AUD | 102.06% |
| 2021 | 3.19 Million AUD | 14.62% |
| 2020 | 2.78 Million AUD | 5.5% |
| 2019 | 2.64 Million AUD | 7.43% |
| 2018 | 2.46 Million AUD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 2.7 Million AUD | 33.19% |
| 2024 Q3 | 3.04 Million AUD | 12.37% |
| 2024 FY | - AUD | -100.0% |
| 2024 Q2 | 2.7 Million AUD | 0.0% |
| 2024 Q4 | 3.04 Million AUD | 0.0% |
| 2023 Q4 | 2.03 Million AUD | 0.0% |
| 2023 FY | 9.8 Million AUD | 51.74% |
| 2023 Q3 | 2.03 Million AUD | -29.04% |
| 2023 Q2 | 2.86 Million AUD | 0.0% |
| 2023 Q1 | 2.86 Million AUD | 56.99% |
| 2022 Q1 | 1.4 Million AUD | 50.55% |
| 2022 FY | 6.45 Million AUD | 102.06% |
| 2022 Q4 | 1.82 Million AUD | 0.0% |
| 2022 Q3 | 1.82 Million AUD | 30.08% |
| 2022 Q2 | 1.4 Million AUD | 0.0% |
| 2021 FY | 3.19 Million AUD | 14.62% |
| 2021 Q1 | 665.87 Thousand AUD | -15.67% |
| 2021 Q4 | 932.35 Thousand AUD | 0.0% |
| 2021 Q2 | 665.87 Thousand AUD | 0.0% |
| 2021 Q3 | 932.35 Thousand AUD | 40.02% |
| 2020 Q1 | 604.81 Thousand AUD | 0.0% |
| 2020 Q2 | 604.81 Thousand AUD | 0.0% |
| 2020 Q4 | 789.59 Thousand AUD | 0.0% |
| 2020 Q3 | 789.59 Thousand AUD | 30.55% |
| 2020 FY | 2.78 Million AUD | 5.5% |
| 2019 FY | 2.64 Million AUD | 7.43% |
| 2018 FY | 2.46 Million AUD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AdAlta Limited | 1.73 Million AUD | -562.141% |
| Acrux Limited | 5.09 Million AUD | -126.02% |
| Race Oncology Limited | 4 Million AUD | -187.417% |
| Biome Australia Limited | 13 Million AUD | 11.548% |
| Botanix Pharmaceuticals Limited | 601.82 Thousand AUD | -1811.978% |
| BTC Health Limited | 16.36 Thousand AUD | -70234.138% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -54.293% |
| CSL Limited | 22.41 Billion AUD | 99.949% |
| Clinuvel Pharmaceuticals Limited | 88.17 Million AUD | 86.951% |
| EZZ Life Science Holdings Limited | 66.44 Million AUD | 82.682% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 3.5 Million AUD | -228.225% |
| Memphasys Limited | 60 Thousand AUD | -19077.775% |
| Neuren Pharmaceuticals Limited | 231.92 Million AUD | 95.039% |
| Noxopharm Limited | 2.4 Million AUD | -379.389% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -209.955% |
| Radiopharm Theranostics Limited | 299.22 Thousand AUD | -3745.451% |
| Starpharma Holdings Limited | 8.28 Million AUD | -38.818% |
| Tissue Repair Ltd | 152.24 Thousand AUD | -7458.24% |
| Biotron Limited | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 4.01 Million AUD | -186.286% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Bio-Gene Technology Limited | 18.32 Thousand AUD | -62709.307% |
| Zelira Therapeutics Limited | 94.95 Thousand AUD | -12018.402% |
| Patrys Limited | 1.39 Million AUD | -725.346% |
| Orthocell Limited | 5.31 Million AUD | -116.479% |
| Imugene Limited | - AUD | -Infinity% |
| PYC Therapeutics Limited | 22.05 Million AUD | 47.838% |
| Proteomics International Laboratories Limited | 892.14 Thousand AUD | -1189.778% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -396.91% |
| Arovella Therapeutics Limited | 17 Thousand AUD | -67586.265% |
| Nanollose Limited | 12.5 Thousand AUD | -91945.956% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -849.194% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Amplia Therapeutics Limited | 4.45 Million AUD | -158.418% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -819.375% |
| Nyrada Inc. | - AUD | -Infinity% |
| Telix Pharmaceuticals Limited | 496.65 Million AUD | 97.683% |
| Dimerix Limited | 583.47 Thousand AUD | -1872.082% |
| PharmAust Limited | - AUD | -Infinity% |
| AnteoTech Limited | 460.39 Thousand AUD | -2399.292% |
| Paradigm Biopharmaceuticals Limited | 65.8 Thousand AUD | -17387.333% |
| Recce Pharmaceuticals Ltd | - AUD | -Infinity% |
| Avecho Biotechnology Limited | 473.55 Thousand AUD | -2329.868% |
| Actinogen Medical Limited | 9.93 Million AUD | -15.86% |
| Immuron Limited | 4.9 Million AUD | -134.693% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -342.915% |